257
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Systemic Immune Inflammatory Response Index Can Predict the Clinical Prognosis of Patients with Initially Diagnosed Coronary Artery Disease

, , , , , & show all
Pages 5069-5082 | Received 21 Aug 2023, Accepted 24 Oct 2023, Published online: 03 Nov 2023

References

  • Dayan N, Filion KB, Okano M, et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753
  • Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177. doi:10.2991/jegh.k.201217.001
  • Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2023;20(1):24–37. doi:10.1038/s41569-022-00737-2
  • Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357(24):2482–2494. doi:10.1056/NEJMra071014
  • Collet JP, Thiele H, Barbato E, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;42(14):1289–1367.
  • Mangalesh S, Dudani S, Mahesh NK. Development of a novel inflammatory index to predict coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2023:33197231151564.
  • Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–285. doi:10.1038/s41569-019-0315-x
  • Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. doi:10.1038/nature05485
  • Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126(9):1260–1280. doi:10.1161/CIRCRESAHA.120.315937
  • Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi:10.3390/ijms23179553
  • Yang Y-L, Wu C-H, Hsu P-F, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
  • Chen Y, Chen S, Han Y, Xu Q, Zhao X. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are important indicators for predicting in-hospital death in elderly AMI patients. J Inflamm Res. 2023;16:2051–2061. doi:10.2147/JIR.S411086
  • Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460. doi:10.1016/j.atherosclerosis.2012.09.009
  • Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395(1–2):27–31. doi:10.1016/j.cca.2008.04.019
  • Song FH, Zheng YY, Tang JN, et al. A correlation between monocyte to lymphocyte ratio and long-term prognosis in patients with coronary artery disease after PCI. Clin Appl Thromb Hemost. 2021;27:1076029621999717. doi:10.1177/1076029621999717
  • Gijsberts CM, Ellenbroek GH, Ten Berg MJ, et al. Routinely analyzed leukocyte characteristics improve prediction of mortality after coronary angiography. Eur J Prev Cardiol. 2016;23(11):1211–1220. doi:10.1177/2047487315621832
  • Trakarnwijitr I, Li B, Adams H, Layland J, Garlick J, Wilson A. Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease. Int J Cardiol. 2017;248:349–354. doi:10.1016/j.ijcard.2017.06.127
  • Qiu Z, Jiang Y, Jiang X, et al. Relationship between platelet to lymphocyte ratio and stable coronary artery disease: meta-analysis of observational studies. Angiology. 2020;71(10):909–915. doi:10.1177/0003319720943810
  • Bressi E, Mangiacapra F, Ricottini E, et al. Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-Year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. J Cardiovasc Transl Res. 2018;11(6):517–523. doi:10.1007/s12265-018-9829-6
  • Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship Between Systemic Immune-Inflammation Index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
  • Shi S, Kong S, Ni W, et al. Association of the systemic immune-inflammation index with outcomes in acute coronary syndrome patients with chronic kidney disease. J Inflamm Res. 2023;16:1343–1356. doi:10.2147/JIR.S397615
  • Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi:10.2147/JIR.S283835
  • Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi:10.1080/07853890.2022.2083671
  • Sabanoglu C, Chang H-P, Chang R-Y, Tai H-Y, Huang Y-W, Lee P-C. H Inanc I. C-reactive protein to albumin ratio predicts for severity of coronary artery disease and ischemia. Eur Rev Med Pharmacol Sci. 2022;26(20):7631–7632. doi:10.26355/eurrev_202210_30039
  • Peizhi W, Deshan Y, Ce Z, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21(1):46. doi:10.1186/s12933-022-01477-w
  • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347–1358doi:10.1016/S0140-6736(21)02391-6
  • Satny M, Hubacek JA, Vrablik M. Statins and Inflammation. Curr Atheroscler Rep. 2021;23(12):80. doi:10.1007/s11883-021-00977-6
  • Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–351. doi:10.1161/CIRCRESAHA.117.310795
  • Quixuan L, Xiaoteng M, Qiaoyu S, et al. Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients. Front cardiovasc med. 2022;3(9):811790.
  • Stergiou GS, Palatini P, Parati G, et al. European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302. doi:10.1097/HJH.0000000000002843
  • Cosentino F, Grant PJ, Aboyans V, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2019;41(2):255–323.
  • Mach F, Baigent C, Catapano AL, et al. ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019;41(1):111–188.
  • Lawton JS, Tamis-Holland JE, Bangalore S, et al. ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;145(3):e18–e114. doi:10.1161/CIR.0000000000001038
  • Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
  • Wang J, Zhou D, Dai Z, Li X. Association between systemic immune-inflammation index and diabetic depression. Clin Interv Aging. 2021;16:97–105. doi:10.2147/CIA.S285000
  • Geraghty JR, Lung TJ, Hirsch Y, et al. Systemic immune-inflammation index predicts delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2021;89(6):1071–1079. doi:10.1093/neuros/nyab354
  • Liu B, Wang J, Li YY, Li KP, Zhang Q. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018. Arthritis Res Ther. 2023;25(1):34. doi:10.1186/s13075-023-03018-6
  • Xu M, Chen R, Liu L, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study. Atherosclerosis. 2021;323:20–29. doi:10.1016/j.atherosclerosis.2021.02.012
  • Xu JP, Zeng RX, Zhang YZ, et al. Systemic inflammation markers and the prevalence of hypertension: a NHANES cross-sectional study. Hypertens Res. 2023;46(4):1009–1019. doi:10.1038/s41440-023-01195-0
  • Wang P, Guo X, Zhou Y, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol. 2022;13:944991. doi:10.3389/fendo.2022.944991
  • Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022;27(1):106. doi:10.1186/s40001-022-00733-9
  • Wang Z, Qin Z, Yuan R, et al. Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction. ESC Heart Fail. 2023;10(1):478–491. doi:10.1002/ehf2.14217
  • Jiang H, Li D, Xu T, et al. Systemic immune-inflammation index predicts contrast-induced acute kidney injury in patients undergoing coronary angiography: a cross-sectional study. Front Med. 2022;9:841601. doi:10.3389/fmed.2022.841601
  • Wang Z, Ruan H, Li L, et al. Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy. Ups J Med Sci. 2021;126. doi:10.48101/ujms.v126.8124
  • Ye Z, Hu T, Wang J, et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis. Front cardiovasc med. 2022;9:933913. doi:10.3389/fcvm.2022.933913
  • Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158–2167. doi:10.1002/cncr.30057
  • Zhao Y, Hong X, Xie X, et al. Preoperative systemic inflammatory response index predicts long-term outcomes in type B aortic dissection after endovascular repair. Front Immunol. 2022;13:992463. doi:10.3389/fimmu.2022.992463
  • Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and Systemic Inflammatory Response Index (SIRI) predict mortality after off-pump coronary artery bypass surgery. Cells. 2022;11(7):1124. doi:10.3390/cells11071124
  • Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896–903. doi:10.1093/eurheartj/ehaa1034
  • Hua Y, Sun JY, Lou YX, Sun W, Kong XQ. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population. Int J Cardiol. 2023;379:118–126. doi:10.1016/j.ijcard.2023.03.016
  • Chen T, Yang M. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients. Int Immunopharmacol. 2020;78:106063. doi:10.1016/j.intimp.2019.106063
  • Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327–340. doi:10.1038/s41569-019-0326-7
  • Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arteriosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol. 2011;31(7):1506–1516. doi:10.1161/ATVBAHA.110.221127
  • Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Sci NY. 2013;339(6116):161–166. doi:10.1126/science.1230719
  • Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177–191.
  • Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102(08):248–257. doi:10.1160/TH09-03-0192
  • von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100(1):27–40. doi:10.1161/01.RES.0000252802.25497.b7
  • Wang RH, Wen WX, Jiang ZP, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023;14:1115031. doi:10.3389/fimmu.2023.1115031